Tango Therapeutics, Inc. TNGX
i
Market datapartial · fetched 2026-11-13T02:49:21.796Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-12T21:31:11.398823926Z
FundamentalsAlpha Vantage · unavailable
Tango Therapeutics, Inc. options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 20.94 | 160.6% | 18.7% | |||
| 25Δ | 21.58 | 181.5% | 17.9% | |||
| 30Δ | ||||||
| 35Δ | 23.53 | 123.7% | 10.1% | |||
| 40Δ | 26.16 | 102.9% | 9.3% | 24.18 | 110.7% | 7.9% |
| 45Δ | 25.61 | 94.8% | 7.4% | 24.69 | 110.0% | 6.8% |
| 50Δ | 25.09 | 85.7% | 5.6% | 25.25 | 113.6% | 6.0% |
| 55Δ | 25.90 | 124.0% | 5.5% | |||
| 60Δ | 26.23 | 114.8% | 4.6% | |||
| 65Δ | 23.65 | 122.7% | 5.0% | 26.50 | 102.0% | 3.5% |
| 70Δ | 23.22 | 108.2% | 3.6% | 26.77 | 89.2% | 2.5% |
| 75Δ | 22.81 | 97.4% | 2.5% | 27.13 | 79.4% | 1.6% |
| 80Δ | 22.44 | 90.3% | 1.8% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 20.94
- IV
- 160.6%
- B/E move
- 18.7%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 21.58
- IV
- 181.5%
- B/E move
- 17.9%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 23.53
- IV
- 123.7%
- B/E move
- 10.1%
40Δ
- Pseudo strike
- 26.16
- IV
- 102.9%
- B/E move
- 9.3%
- Pseudo strike
- 24.18
- IV
- 110.7%
- B/E move
- 7.9%
45Δ
- Pseudo strike
- 25.61
- IV
- 94.8%
- B/E move
- 7.4%
- Pseudo strike
- 24.69
- IV
- 110.0%
- B/E move
- 6.8%
50Δ
- Pseudo strike
- 25.09
- IV
- 85.7%
- B/E move
- 5.6%
- Pseudo strike
- 25.25
- IV
- 113.6%
- B/E move
- 6.0%
55Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 25.90
- IV
- 124.0%
- B/E move
- 5.5%
60Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 26.23
- IV
- 114.8%
- B/E move
- 4.6%
65Δ
- Pseudo strike
- 23.65
- IV
- 122.7%
- B/E move
- 5.0%
- Pseudo strike
- 26.50
- IV
- 102.0%
- B/E move
- 3.5%
70Δ
- Pseudo strike
- 23.22
- IV
- 108.2%
- B/E move
- 3.6%
- Pseudo strike
- 26.77
- IV
- 89.2%
- B/E move
- 2.5%
75Δ
- Pseudo strike
- 22.81
- IV
- 97.4%
- B/E move
- 2.5%
- Pseudo strike
- 27.13
- IV
- 79.4%
- B/E move
- 1.6%
80Δ
- Pseudo strike
- 22.44
- IV
- 90.3%
- B/E move
- 1.8%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 110.55% | |
| 113.99% | |
| 114.72% | |
| 112.64% | |
| 82.83% | |
| 81.29% | |
| 88.59% | |
| 87.47% | |
| 86.55% | |
| 89.99% |
Biotechnology
TNXP
Tonix Pharmaceuticals Holding Corp. The company is headquartered in Chatham, New Jersey.
More →TNYA
Tenaya Therapeutics Inc. is a pioneering clinical-stage biotechnology firm that is revolutionizing the treatment of heart disease through its proprietary engineered heart cell…
More →TRAX
First Tracks Biotherapeutics (Ticker: TRAX) is a forward-thinking biotechnology company focused on developing targeted therapeutics for chronic diseases, utilizing advanced…
More →TRDA
Description unavailable
More →TRVI
Description unavailable
More →TSHA
Description unavailable
More →